Bank of America Issues Positive Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its target price increased by Bank of America from $430.00 to $470.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have a neutral rating on the stock.

HCA has been the topic of a number of other research reports. Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. The Goldman Sachs Group boosted their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday. Robert W. Baird boosted their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. Mizuho boosted their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a research report on Monday. Finally, Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $471.42.

HCA Healthcare Trading Up 4.8%

NYSE:HCA opened at $468.68 on Monday. The stock has a market capitalization of $109.67 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 1.41 and a beta of 1.40. The firm’s 50 day moving average is $416.33 and its 200 day moving average is $383.23. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $469.18.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts predict that HCA Healthcare will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 1.30% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the company. LVZ Inc. raised its stake in shares of HCA Healthcare by 24.4% during the third quarter. LVZ Inc. now owns 1,537 shares of the company’s stock valued at $655,000 after acquiring an additional 301 shares during the last quarter. Kera Capital Partners Inc. raised its stake in shares of HCA Healthcare by 82.8% during the third quarter. Kera Capital Partners Inc. now owns 1,053 shares of the company’s stock valued at $449,000 after acquiring an additional 477 shares during the last quarter. Exencial Wealth Advisors LLC bought a new position in HCA Healthcare in the third quarter worth about $239,000. Concurrent Investment Advisors LLC raised its stake in HCA Healthcare by 2.3% in the third quarter. Concurrent Investment Advisors LLC now owns 2,286 shares of the company’s stock worth $974,000 after buying an additional 51 shares in the last quarter. Finally, GRIMES & Co WEALTH MANAGEMENT LLC bought a new position in HCA Healthcare in the third quarter worth about $207,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.